Combinatorial strategies for oncolytic herpes simplex virus therapy of brain tumors

Por Kanai, Ryuichi, Rabkin, Samuel D
Publicado em 2013

Designing herpes viruses as oncolytics

Por Peters, Cole, Rabkin, Samuel D
Publicado no Mol Ther Oncolytics (2015)

Prospect and progress of oncolytic viruses for treating peripheral nerve sheath tumors

Por Antoszczyk, Slawomir, Rabkin, Samuel D.
Publicado no Expert Opin Orphan Drugs (2015)

Current status of gene therapy for brain tumors

Por MURPHY, ANDREA M., RABKIN, SAMUEL D.
Publicado em 2012

Immunovirotherapy for glioblastoma

Por Ning, Jianfang, Wakimoto, Hiroaki, Rabkin, Samuel D
Publicado em 2014

EXPLORING THE ANTITUMOR EFFECT OF VIRUS IN MALIGNANT GLIOMA

Por Saha, Dipongkor, Ahmed, Seemin S., Rabkin, Samuel D.
Publicado no Drugs Future (2015)

Oncolytic herpes simplex virus interactions with the host immune system

Por Saha, Dipongkor, Wakimoto, Hiroaki, Rabkin, Samuel D.
Publicado no Curr Opin Virol (2016)

MACROPHAGE POLARIZATION CONTRIBUTES TO GLIOBLASTOMA ERADICATION BY COMBINATION IMMUNOVIROTHERAPY AND IMMUNE CHECKPOINT BLOCKADE

Por Saha, Dipongkor, Martuza, Robert L., Rabkin, Samuel D.
Publicado no Cancer Cell (2017)

Curing glioblastoma: oncolytic HSV-IL12 and checkpoint blockade

Por Saha, Dipongkor, Martuza, Robert L., Rabkin, Samuel D.
Publicado no Oncoscience (2017)

Oncolytic herpes simplex virus vectors and chemotherapy: are combinatorial strategies more effective for cancer?

Por Kanai, Ryuichi, Wakimoto, Hiroaki, Cheema, Tooba, Rabkin, Samuel D
Publicado em 2010

Replication-Competent Herpes Simplex Virus Vector G207 and Cisplatin Combination Therapy for Head and Neck Squamous Cell Carcinoma

Por Chahlavi, Ali, Todo, Tomoki, Martuza, Robert L, Rabkin, Samuel D
Publicado em 1999

Flip-Flop HSV-BAC: bacterial artificial chromosome based system for rapid generation of recombinant herpes simplex virus vectors using two independent site-specific recombinases

Por Kuroda, Toshihiko, Martuza, Robert L, Todo, Tomoki, Rabkin, Samuel D
Publicado em 2006

A Novel Oncolytic Herpes Simplex Virus that Synergizes with Phosphatidylinositol 3-Kinase/Akt Pathway Inhibitors to Target Glioblastoma Stem Cells

Por Kanai, Ryuichi, Wakimoto, Hiroaki, Martuza, Robert L., Rabkin, Samuel D.
Publicado em 2011

ET-17 TRANSIENT FASTING ENHANCES REPLICATION AND THERAPEUTIC ACTIVITY OF ONCOLYTIC HSV IN GLIOBLASTOMA THERAPY

Por Esaki, Shinichi, Rabkin, Samuel D., Martuza, Robert L., Wakimoto, Hiroaki
Publicado em 2014

Transient fasting enhances replication of oncolytic herpes simplex virus in glioblastoma

Por Esaki, Shinichi, Rabkin, Samuel D, Martuza, Robert L, Wakimoto, Hiroaki
Publicado no Am J Cancer Res (2016)

Oncolytic viruses on the cusp of success?: proceedings of the 9th International Conference on Oncolytic Virus Therapeutics

Por Peters, Cole, Nigim, Fares, Chiocca, E Antonio, Rabkin, Samuel D
Publicado no Mol Ther Oncolytics (2016)

Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing

Por Todo, Tomoki, Martuza, Robert L., Rabkin, Samuel D., Johnson, Paul A.
Publicado em 2001

Attenuated, Replication-Competent Herpes Simplex Virus Type 1 Mutant G207: Safety Evaluation in Mice

Por Sundaresan, Periasamy, Hunter, William D., Martuza, Robert L., Rabkin, Samuel D.
Publicado em 2000

Immunovirotherapy for the treatment of glioblastoma

Por Cheema, Tooba A, Fecci, Peter E, Ning, Jianfang, Rabkin, Samuel D
Publicado em 2014

Trichostatin A and Oncolytic HSV Combination Therapy Shows Enhanced Antitumoral and Antiangiogenic Effects

Por Liu, Ta-Chiang, Castelo Branco, Pedro, Rabkin, Samuel D., Martuza, Robert L.
Publicado em 2008